- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- January 2026
- 199 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- January 2026
- 182 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- August 2025
- 192 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- August 2025
- 191 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- August 2025
- 195 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- May 2026
- 224 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 466 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 419 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 577 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 466 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 384 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 181 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 376 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 462 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 168 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 392 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 218 Pages
Global
From €5196EUR$5,850USD£4,527GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more